Literature DB >> 24798748

Second generation imaging of nuclear/cytoplasmic HIV-1 complexes.

Ashwanth Christopher Francis1, Cristina Di Primio, Valentina Quercioli, Paola Valentini, Annegret Boll, Gabriele Girelli, Francesca Demichelis, Daniele Arosio, Anna Cereseto.   

Abstract

The ability to visualize fluorescent HIV-1 particles within the nuclei of infected cells represents an attractive tool to study the nuclear biology of the virus. To this aim we recently developed a microscopy-based fluorescent system (HIV-IN-EGFP) that has proven valid to efficiently visualize HIV-1 complexes in the nuclear compartment and to examine the nuclear import efficiency of the virus. The power of this method to investigate viral events occurring between the cytoplasmic and the nuclear compartment is further shown in this study through the analysis of HIV-IN-EGFP in cells expressing the TRIMCyp restriction factor. In these cells the HIV-IN-EGFP complexes are not detected in the nuclear compartment, while treatment with MG132 reveals an accumulation of HIV-1 complexes in the cytoplasm. However, the Vpr-mediated transincorporation strategy used to incorporate IN fused to EGFP (IN-EGFP) impaired viral infectivity. To optimize the infectivity of the HIV-IN-EGFP, we used mutated forms of IN (E11K and K186E) known to stabilize the IN complexes and to partially restore viral infectivity in transcomplementation experiments. The fluorescent particles produced with the modified IN [HIV-IN(K)EGFP_IN(E)] show almost 30% infectivity as compared to wild-type NL4.3. Detailed confocal microscopy analysis revealed that the newly generated viral particles resulted in HIV-1 complexes significantly smaller in size, thus requiring the use of brighter fluorophores for nuclear visualization [HIV-IN(K)sfGFP_IN(E)]. The second-generation visualization system HIV-IN(K)sfGFP_IN(E), in addition to allowing direct visualization of HIV-1 nuclear entry and other viral events related to nuclear import, preserves intact viral properties in terms of nuclear entry and improved infectivity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24798748      PMCID: PMC4077004          DOI: 10.1089/AID.2013.0277

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  31 in total

1.  A quantitative assay for HIV DNA integration in vivo.

Authors:  S L Butler; M S Hansen; F D Bushman
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  Time-resolved imaging of HIV-1 Env-mediated lipid and content mixing between a single virion and cell membrane.

Authors:  Ruben M Markosyan; Fredric S Cohen; Grigory B Melikyan
Journal:  Mol Biol Cell       Date:  2005-09-29       Impact factor: 4.138

3.  Engineering and characterization of a superfolder green fluorescent protein.

Authors:  Jean-Denis Pédelacq; Stéphanie Cabantous; Timothy Tran; Thomas C Terwilliger; Geoffrey S Waldo
Journal:  Nat Biotechnol       Date:  2005-12-20       Impact factor: 54.908

4.  Nuclear import of APOBEC3F-labeled HIV-1 preintegration complexes.

Authors:  Ryan C Burdick; Wei-Shau Hu; Vinay K Pathak
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

5.  Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type 1 integrase.

Authors:  Richard Lu; Ana Limón; Hina Z Ghory; Alan Engelman
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Genetic analyses of conserved residues in the carboxyl-terminal domain of human immunodeficiency virus type 1 integrase.

Authors:  Richard Lu; Hina Z Ghory; Alan Engelman
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  Lys-34, dispensable for integrase catalysis, is required for preintegration complex function and human immunodeficiency virus type 1 replication.

Authors:  Richard Lu; Nick Vandegraaff; Peter Cherepanov; Alan Engelman
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1.

Authors:  David M Sayah; Elena Sokolskaja; Lionel Berthoux; Jeremy Luban
Journal:  Nature       Date:  2004-07-07       Impact factor: 49.962

9.  Class II integrase mutants with changes in putative nuclear localization signals are primarily blocked at a postnuclear entry step of human immunodeficiency virus type 1 replication.

Authors:  Richard Lu; Ana Limón; Eric Devroe; Pamela A Silver; Peter Cherepanov; Alan Engelman
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

10.  Intracytoplasmic maturation of the human immunodeficiency virus type 1 reverse transcription complexes determines their capacity to integrate into chromatin.

Authors:  Sergey Iordanskiy; Reem Berro; Maria Altieri; Fatah Kashanchi; Michael Bukrinsky
Journal:  Retrovirology       Date:  2006-01-12       Impact factor: 4.602

View more
  21 in total

1.  Capsid-CPSF6 interaction: Master regulator of nuclear HIV-1 positioning and integration.

Authors:  Vasudevan Achuthan; Jill M Perreira; Jenny J Ahn; Abraham L Brass; Alan N Engelman
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

2.  Comparative Analysis of HIV-1 and Murine Leukemia Virus Three-Dimensional Nuclear Distributions.

Authors:  Valentina Quercioli; Cristina Di Primio; Antonio Casini; Lubbertus C F Mulder; Lenard S Vranckx; Doortje Borrenberghs; Rik Gijsbers; Zeger Debyser; Anna Cereseto
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

3.  An improved labeling strategy enables automated detection of single-virus fusion and assessment of HIV-1 protease activity in single virions.

Authors:  Chetan Sood; Ashwanth C Francis; Tanay M Desai; Gregory B Melikyan
Journal:  J Biol Chem       Date:  2017-10-18       Impact factor: 5.157

4.  Facile autofluorescence suppression enabling tracking of single viruses in live cells.

Authors:  Yen-Cheng Chen; Chetan Sood; Ashwanth C Francis; Gregory B Melikyan; Robert M Dickson
Journal:  J Biol Chem       Date:  2019-11-06       Impact factor: 5.157

5.  Imaging HIV-1 Genomic DNA from Entry through Productive Infection.

Authors:  Ryan D Stultz; Jennifer J Cenker; David McDonald
Journal:  J Virol       Date:  2017-04-13       Impact factor: 5.103

6.  C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation.

Authors:  Nausicaa V Licata; Riccardo Cristofani; Sally Salomonsson; Katherine M Wilson; Liam Kempthorne; Deniz Vaizoglu; Vito G D'Agostino; Daniele Pollini; Rosa Loffredo; Michael Pancher; Valentina Adami; Paola Bellosta; Antonia Ratti; Gabriella Viero; Alessandro Quattrone; Adrian M Isaacs; Angelo Poletti; Alessandro Provenzani
Journal:  EMBO J       Date:  2021-11-18       Impact factor: 11.598

7.  Single HIV-1 Imaging Reveals Progression of Infection through CA-Dependent Steps of Docking at the Nuclear Pore, Uncoating, and Nuclear Transport.

Authors:  Ashwanth C Francis; Gregory B Melikyan
Journal:  Cell Host Microbe       Date:  2018-04-11       Impact factor: 21.023

8.  Capsid Lattice Destabilization Leads to Premature Loss of the Viral Genome and Integrase Enzyme during HIV-1 Infection.

Authors:  Jenna E Eschbach; Jennifer L Elliott; Wen Li; Kaneil K Zadrozny; Keanu Davis; Shawn J Mohammed; Dana Q Lawson; Owen Pornillos; Alan N Engelman; Sebla B Kutluay
Journal:  J Virol       Date:  2020-12-22       Impact factor: 5.103

9.  Direct Visualization of HIV-1 Replication Intermediates Shows that Capsid and CPSF6 Modulate HIV-1 Intra-nuclear Invasion and Integration.

Authors:  Christopher R Chin; Jill M Perreira; George Savidis; Jocelyn M Portmann; Aaron M Aker; Eric M Feeley; Miles C Smith; Abraham L Brass
Journal:  Cell Rep       Date:  2015-11-12       Impact factor: 9.423

Review 10.  Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges.

Authors:  Kristine E Yoder; Anthony J Rabe; Richard Fishel; Ross C Larue
Journal:  Front Mol Biosci       Date:  2021-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.